Moody Aldrich Partners’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,256
Closed -$1.96M 180
2021
Q1
$1.96M Buy
2,256
+33
+1% +$28.6K 0.28% 94
2020
Q4
$2.06M Buy
2,223
+2
+0.1% +$1.85K 0.33% 91
2020
Q3
$2.28M Buy
2,221
+61
+3% +$62.7K 0.48% 86
2020
Q2
$2.19M Buy
2,160
+305
+16% +$309K 0.47% 81
2020
Q1
$1.61M Buy
+1,855
New +$1.61M 0.49% 76
2018
Q4
Sell
-1,353
Closed -$2.06M 101
2018
Q3
$2.06M Buy
1,353
+209
+18% +$317K 0.59% 77
2018
Q2
$1.79M Buy
1,144
+84
+8% +$131K 0.64% 72
2018
Q1
$1.22M Buy
1,060
+249
+31% +$288K 0.79% 66
2017
Q4
$961K Buy
811
+169
+26% +$200K 0.78% 64
2017
Q3
$864K Buy
642
+85
+15% +$114K 0.89% 54
2017
Q2
$450K Buy
+557
New +$450K 0.56% 81